{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699993476575360.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.pnmrs.2012.09.001"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0079656512000957?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0079656512000957?httpAccept=text/plain"}}],"dc:title":[{"@value":"Human serum/plasma lipoprotein analysis by NMR: Application to the study of diabetic dyslipidemia"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699993476575360","@type":"Researcher","foaf:name":[{"@value":"Roger Mallol"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993476575361","@type":"Researcher","foaf:name":[{"@value":"Miguel Angel Rodriguez"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993476575364","@type":"Researcher","foaf:name":[{"@value":"Jesus Brezmes"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993476575363","@type":"Researcher","foaf:name":[{"@value":"Lluis Masana"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993476575362","@type":"Researcher","foaf:name":[{"@value":"Xavier Correig"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00796565"}],"prism:publicationName":[{"@value":"Progress in Nuclear Magnetic Resonance Spectroscopy"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2013-04","prism:volume":"70","prism:startingPage":"1","prism:endingPage":"24"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0079656512000957?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0079656512000957?httpAccept=text/plain"}],"createdAt":"2012-09-11","modifiedAt":"2023-06-25","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282679067705472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Recent Advances in Analytical Methods on Lipoprotein Subclasses: Calculation of Particle Numbers from Lipid Levels by Gel Permeation HPLC Using “Spherical Particle Model”"},{"@value":"Gel Permeation HPLC Analysis Validates a Classical Spherical Space-filling Model for Lipoprotein Structure Opening Future Potential of the Technology"},{"@value":"Recent Advances in Analytical Methods on Lipoprotein Subclasses: Caluculation of Particle Numbers from Lipid Levels by Gel Permeation HPLC Using “Spherical Particle Model”"}]},{"@id":"https://cir.nii.ac.jp/crid/1390570707165936896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate"},{"@value":"Distinct differences in lipoprotein particle number evaluation between GP-HPLC and NMR: Analysis in dyslipidemic patients administered a selective PPARα modulator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.pnmrs.2012.09.001"},{"@type":"CROSSREF","@value":"10.5551/jat.60764_references_DOI_TCfvpXkaPX9VI1w5EXNMhSj6dZP"},{"@type":"CROSSREF","@value":"10.5650/jos.ess16501_references_DOI_TCfvpXkaPX9VI1w5EXNMhSj6dZP"},{"@type":"CROSSREF","@value":"10.5650/jos.ess16020_references_DOI_TCfvpXkaPX9VI1w5EXNMhSj6dZP"}]}